|
ZNF222 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.710200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.041800E-04 |
| Normal-vs-Stage2 |
8.781600E-01 |
| Normal-vs-Stage3 |
4.679900E-02 |
| Normal-vs-Stage4 |
1.303080E-03 |
| Stage1-vs-Stage2 |
4.304400E-02 |
| Stage1-vs-Stage3 |
5.0810999963069E-08 |
| Stage1-vs-Stage4 |
1.06209996353357E-09 |
| Stage2-vs-Stage3 |
1.910240E-01 |
| Stage2-vs-Stage4 |
2.897900E-02 |
| Stage3-vs-Stage4 |
1.525230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.576000E-01 |
| Normal-vs-AfricanAmerican |
1.401430E-01 |
| Normal-vs-Asian |
7.119800E-01 |
| Caucasian-vs-AfricanAmerican |
1.781820E-01 |
| Caucasian-vs-Asian |
7.672800E-01 |
| AfricanAmerican-vs-Asian |
8.349600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.559400E-01 |
| Normal-vs-Female |
1.236020E-01 |
| Male-vs-Female |
1.854580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.028600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.549960E-01 |
| Normal-vs-Age(61-80Yrs) |
9.301400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.343400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.934800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.971600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.667000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.756840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.022600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.001600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.360800E-03 |
| Normal-vs-Grade 2 |
1.621970E-03 |
| Normal-vs-Grade 3 |
3.186000E-01 |
| Normal-vs-Grade 4 |
2.216000E-03 |
| Grade 1-vs-Grade 2 |
4.786300E-02 |
| Grade 1-vs-Grade 3 |
1.360150E-04 |
| Grade 1-vs-Grade 4 |
1.37249999998534E-06 |
| Grade 2-vs-Grade 3 |
4.19849999999666E-05 |
| Grade 2-vs-Grade 4 |
5.91450000086979E-08 |
| Grade 3-vs-Grade 4 |
2.438100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.156300E-03 |
| Normal-vs-ccB subtype |
4.290800E-01 |
| ccA subtype-vs-ccB subtype |
2.980200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.972000E-01 |
| Normal-vs-N1 |
2.001800E-01 |
| N0-vs-N1 |
1.944230E-01 |
|
|
